Skip to main content
. Author manuscript; available in PMC: 2021 Jul 20.
Published in final edited form as: J Control Release. 2018 Jun 28;286:210–223. doi: 10.1016/j.jconrel.2018.06.030

Table 1.

Comparison of the known effect of chromatin modifying enzyme targets on genomic gene expression and transgene expression as observed in the screen.

Target Modulator Enzyme Effect on Endogenous Chromatin Expression Activity Inhibitor Effect on Transient Luciferase (Transgene) Expression
EZH2 Repression[52] Activation
Gadd45 Activation [53] Repression
HAT (CBP/p300) Activation [54] Repression
HDAC/Sirtuin Repression [55] Activation
LSD1 Repression [56] Activation
HAT (Gcn5/PCAF) Activation [57] Activation
WDR5/Menin-MLL* Activation* [58] Activation
*

WDR5 and Menin are non-catalytic components of H3K4 methyltransferase complex